Tina Danielzik

Tina Danielzik is an accomplished professional in the field of biopharmaceuticals, currently serving as the Product Quality Lead at Polpharma Biologics since May 2021, where responsibilities include coordinating quality functions for biosimilar programs and overseeing analytical method development. Previously, Tina held positions such as Analytical Project Lead and BioAnalytical Scientist II and Project Lead at Lonza, where expertise in project management and regulatory compliance was demonstrated. Early career highlights include serving as a Senior Development Scientist at Oxford Immunotec, contributing to product development, and completing a PhD at the University Hospital Essen, focused on adoptive immunotherapy for Acute Myeloid Leukemia. Tina holds degrees in Immunology and Cellular Biology from the BIOME Graduate School and a Master’s degree in Biomedical Science from King’s College London.